English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    N. Ya. Chuiko, D. S. Mankovskiy, O. G. Kuryk, L. A. Cherkasova, O. L. Kisilenko, K. V. Bazdyrev, V. V. Verbitskiy

    CHANGES IN THE PHENOTYPE OF VASCULAR WALL CELLS IN CEREBROVASCULAR ATHEROSCLEROSIS IN PATIENTS WITH ISCHEMIC STROKE


    About the author: N. Ya. Chuiko, D. S. Mankovskiy, O. G. Kuryk, L. A. Cherkasova, O. L. Kisilenko, K. V. Bazdyrev, V. V. Verbitskiy
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Nowadays, there is a lot of experimental and clinical evidence that atherosclerosis is a chronic inflammatory disease with an autoimmune component. Endothelial damage causes a cascade of inflammatory reactions involving monocytes, macrophages, T-lymphocytes, and vascular smooth muscle cells. In recent years, the pathogenesis of atherosclerosis has been associated with monoclonal proliferation of smooth muscle cells. The article studies the brain arteries’ smooth muscle cells of the vascular walls in atherosclerosis in patients with ischemic stroke. It was determined that when cerebral vessels are damaged by atherosclerosis, there are subpopulations of smooth muscle cells in the vascular wall, which are characterized by the expression of desmin; smooth muscle cells are able to change their phenotype from contractile to synthetic, and this particular change in phenotype is one of the key points in the pathogenesis of atherosclerosis. This change of smooth muscle cells’ phenotype in the endarterium activates proliferation and active synthesis of the connective tissue matrix components, i. e. the modified smooth muscle cells are responsible for the fibrous plaque insula formation.
    Tags smooth muscle cells of vascular wall, immune response, atherosclerotic plaques
    Bibliography
    • Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692–702. https://doi.org/10.1161/CIRCRESAHA.115.306361
    • Cochain C, Zernecke A. Macrophages and immune cells in atherosclerosis: recent advances and novel concepts. Basic Res Cardiol. 2015;110(4):34 doi: 10.1007/s00395-015-0491-8.
    • Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Garcia-Ruiz JM, Mendiguren J et al. Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J AmColl Cardiol. 2017;70(24):2979–2991. https://doi.org/10.1016/j.jacc.2017.10.024
    • Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED,  Amadori L et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019;25(10):1576–1588. https://doi.org/10.1038/s41591-019-0590-4.
    • Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E et al. European Society of Cardiology Working Group on Peripheral Circulation. Non-coronary atherosclerosis. Eur Heart J. 2014;35(17):1112–9. https://doi.org/10.1093/eurheartj/ehu071.
    • Georgakis MK, Gill D, Rannikmäe K, Traylor M, Anderson CD, Lee JM et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139(2):256–268. https://doi.org/10.1161/CIRCULATIONAHA.118.035905
    • Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016;118:535–546. http://dx.doi.org/10.1161/CIRCRESAHA.115.307611
    • Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018;123:1118–1120. https://doi.org/10.1161/CIRCRESAHA.118.313816
    • Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet. 2018; 392:2203–2212. https://doi.org/10.1016/S0140-6736(18)31668-4
    • Libby P. History of discovery: inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9):2045–2051. https://doi.org/10.1161/ATVBAHA.108.179705
    • Libby P, Hansson GK, Lichtman AH. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092–104. https://doi.org/10.1016/j.immuni.2013.06.009
    • Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A et al. Exome-wide association study of plasma lipids in >300,000 individuals.Nat Genet.2017;49(12):1758–1766. https://doi.org/10.1038/ng.3977.
    • Perrins C.J., Bobryshev Y.V. Current advances in understanding of immunopathology of atherosclerosis. Virchows Arch. 2011;458(2):117–23. https://doi.org/10.1007/s00428-010-1006-5.
    • Shi N, Chen SY. Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases. J Cell Physiol. 2016;231(4):777–87. https://doi.org/10.1002/jcp.25208
    • Tabas I., Lichtman AH. Monocyte-macrophages and T cells in atherosclerosis. Immunity. 2017;47(4):621–634. doi: 10.1016/j.immuni.2017.09.008.
    Publication of the article «World of Medicine and Biology» №3(77), 2021 year, 179-184 pages, index UDK 616 - 008.9 – 06:616.381 – 005.4 – 091.8
    DOI 10.26724/2079-8334-2021-3-77-179-184